Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.875
Bid: 3.75
Ask: 4.00
Change: -0.50 (-11.43%)
Spread: 0.25 (6.667%)
Open: 4.375
High: 4.375
Low: 3.875
Prev. Close: 4.375
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Solid 2021 for Ten Entertainment, Central Asia Metals

Tue, 29th Mar 2022 17:05

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Central Asia Metals PLC - copper, zinc and lead explorer operating in Kazakhstan and North Macedonia - For 2021, pretax profit rises 83% to a record of USD109.3 million from USD59.8 million the year before, on record net revenue which increases 40% to USD223.4 million from USD160.1 million. Produces 14,041 tonnes of copper, 22,167 tonnes of zinc and 27,202 tonnes of lead. Declares final dividend of 12 pence per share, bringing the total payout to 20p, up 43% from 14p in 2020. Looking ahead, expects Kounrad copper output for 2022 between 12,500 tonnes and 13,500 tonnes, while Sasa is set to produce between 20,000 to 22,000 tonnes in zinc, and 27,000 to 29,000 tonnes in lead.

----------

Ten Entertainment Group PLC - Bedford, England-based ten pin bowling and family entertainment centres operator - For the year ended December 26, swings to pretax profit of GBP4.4 million, from a loss of GBP21.7 million the year before, on revenue which jumps 86% to GBP67.5 million from GBP36.8 million, but remained 20% short of pre-virus levels. Looking ahead, for the 2022 financial year, sales growth for the first 12 weeks have increased 42% from the same period in 2019. In addition, annual profit is set to be ahead of market expectations, and is looking to pay a dividend for the 2022 financial year.

----------

Northamber PLC - London-based distributor of AV & IT equipment - For the six months ended December 31, sinks to pretax loss of GBP116,000 from a profit of GBP223,000 a year prior, on higher distribution and administrative costs from the company's investment in developing its team, in spite of 8.8% revenue growth to GBP32.3 million from GBP29.7 million. Declares interim dividend of 0.3 pence per share, in line with a year prior.

----------

Condor Gold PLC - mine developer in Nicaragua - For 2021, pretax loss widens to GBP2.3 million from GBP1.3 million, driven by higher expenses and a lack of gain on the disposal of a project in 2020. During the year, had completed a preliminary economic assessment on the La India project in September, and an infill drilling program on La India's high grade starter pits. Looking ahead, company notes robust results from infill drilling, which will contribute towards a future feasibility study.

----------

James Latham PLC - timber and panel products distributor - Revenue for the year ending March 31 is expected to beat the GBP370 million mark, compared to GBP250 million the year before, attributed to increasing cost prices, more than offsetting slowing volume growth.

----------

Westmount Energy Ltd - Jersey-headquartered investor in oil and gas industries - For the six months ended December 31, pretax loss widens to GBP7.0 million from GBP1.2 million a year prior, driven by a wider loss on financial assets held at fair value. During the year, Westmount has continued laying the groundwork for the next drilling campaigns on the Kaieteur and Canje block, while the environmental permitting process is ongoing at the Guyanese EPA.

----------

Genedrive PLC - Manchester-based molecular diagnostics company - For the six months ended December 31, swings to pretax loss of GBP2.8 million from profit of GBP621,000, as revenue plunged to GBP2,000 from GBP355,000, due to a delay in product development of two new point of care products.

----------

Orchard Funding Group PLC - Luton, England-based professional fee funding and insurance premium funding - For the six months ended January 31, pretax profit hikes 64% to GBP997,000 from GBP605,000 a year prior, on a 31% rise from net interest income to GBP2.1 million from GBP1.6 million. Lending volumes grows 27% to GBP38.2 million from GBP30.0 million, on growing demand in the direct insurance market. Declares dividend of 1.0 pence per share, in line with year before.

----------

Highcroft Investments PLC - real estate investment trust - For 2021, swings to profit of GBP12.2 million from a loss of GBP1.1 million, due to a wider gain on investment property at GBP9.9 million from GBP2.5 million. This more than offsets a 3.8% drop in net property income to GBP5.3 million from GBP5.5 million. As at December 31, net asset value per share rises 16% year-on-year to 1,275 pence from 1,104p, as Highcroft's portfolio value increases 6.7% to GBP87.6 million from GBP82.1 million. Declares final dividend of 33 pence per share, bringing the total payout to 55p, down 3.5% from 57p.

----------

Regional REIT Ltd - London-based real estate investment trust - For 2021, swings to pretax profit of GBP28.8 million from loss of GBP31.2 million the year before, due to a narrowed loss in the fair value of investment properties, and a 4.3% increase in net rental and property income to GBP55.8 million from GBP53.3 million. Rent roll rises 12% to GBP72.1 million from GBP64.2 million, while as at December 31, net asset value per share dips to 97.4 pence from 97.5p, in spite of a 24% rise in portfolio value to GBP906.1 million from GBP732.4 million. Declares dividend of 6.50 pence per share, up from 6.40p in 2020.

----------

CPPGroup PLC - Leeds-based products and services for financial services and insurance sectors - For 2021, pretax profit hikes to GBP4.2 million from GBP892,000 the year before, on revenue which grows 5% to GBP143.6 million from GBP136.5 million in 2020. Revenue increases 11% on a constant currency basis. Revenue growth was fostered by a strong performance in India, CPP's largest business. However, the group declared a dividend of 12.5 pence per share, down 50% from 25.0p the year before, following the resetting of CPP's earnings expectations in January.

----------

Animalcare Group PLC - York-based veterinary sales and marketing - For 2021, pretax profit hikes to GBP945,000 from GBP199,000 the year before, on revenue which grows 5.0% annually to GBP74.0 million from GBP70.5 million, driven by exceptional veterinary demand in the first quarter, while markets return to more normal levels. Proposes final dividend of 2.4 pence per share, up 20% from 2.0p in 2020. Looking ahead, expects attractive fundamentals in 2021 to drive sales growth in 2022.

----------

Schiehallion Fund Ltd - makes minority investments in later stage private businesses which have potential to become publicly-traded - As at January 31, net asset value per share rises to 158.20 cents from 146.99 cents the year before, while pretax profit falls to USD30.3 million from USD208.3 million, due to a plunge from the gains on investments. Notes that it has no direct exposure to Russia or Ukraine.

----------

Digitalbox PLC - Bath, England-based mobile-first digital media business - For 2021, swings to pretax profit of GBP627,000 from a loss of GBP143,000 the year before, on revenue which grows 68% year-on-year to GBP3.7 million from GBP2.2 million, driven by an 82% rise in its user base. Trading for 2022 to date has remained strong and in-line with market expectations.

----------

One Heritage Group PLC - residential property developer in north-west England - For the six months ended December 31, pretax loss widens to GBP525,307 from GBP226,986 a year prior, as revenue declines % to GBP148,946 from GBP187,605. Looking ahead, remains cautious on market volatility caused by pressure on material prices, labour and energy prices, but hopes that overseas demand and strong pre-sales will offer some protection.

----------

IQE PLC - Cardiff, Wales-based semiconductor wafer products - For 2021, swings to pretax loss of GBP19.3 million from profit of GBP2.7 million, on revenue which drops 13% to GBP154.1 million from GBP178.0 million. On a constant currency basis, revenue fell 7%. This is due to a reduction in demand from GaN wafers used in 5G infrastructure, and a fall in Photonics revenue as a result of delays experienced in certain aerospace and security orders. Looking ahead, expects revenue growth in 2022 at low single digits at a constant currency basis.

----------

Bioventix PLC - London-based biotechnology company - For the six months ended December 31, pretax profit drops to GBP3.6 million from GBP3.7 million a year before, on revenue which declines 8% to GBP4.7 million from GBP5.2 million as the Covid pandemic affects activity within diagnostic pathways in hospitals and clinics.In addition, sales associated with assay formats fell due to price erosion in downstream markets. IN spite of this, declared interim dividend of 52 pence per share, up 20% from 43p.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
28 Jan 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
3 Dec 2019 10:10

Genedrive Antibiotic Induced Hearing Loss Test Kit Shows High Accuracy

Genedrive Antibiotic Induced Hearing Loss Test Kit Shows High Accuracy

Read more
3 Dec 2019 09:39

Genedrive upbeat on latest results from RNR1 kit testing

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Tuesday that in its case-control clinical validation, the antibiotic-induced hearing loss assay - the 'Genedrive MT-RNR1 ID' kit - achieved a diagnostic sensitivity of 100% and specificity of 100% on a cohort of 303 samples.

Read more
18 Nov 2019 16:00

Genedrive infant hearing loss test gets CE mark

(Sharecast News) - Molecular diagnostics company Genedrive announced on Monday that its antibiotic-induced hearing loss test, the 'Genedrive MT-RNR1 ID' kit, has obtained CE marking.

Read more
18 Nov 2019 11:15

Genedrive's Antibiotic Induced Hearing Loss Assay Receives CE Marking

Genedrive's Antibiotic Induced Hearing Loss Assay Receives CE Marking

Read more
7 Oct 2019 11:59

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

Read more
3 Oct 2019 11:00

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

Read more
3 Oct 2019 10:41

Genedrive loss narrowed after double-digit revenue rise

(Sharecast News) - Genedrive on Thursday reported a narrowed annual loss as revenues jumped as its commercial relationship with the US department of defense (DoD) exceeded expectations.

Read more
9 Jul 2019 10:54

Genedrive Revenue To Suffer On Lower Uptake Of Hepatitis Test Kits

(Alliance News) - Shares in Genedrive PLC fell Tuesday after the company warned that it will miss market expectations for 2020 financial year revenue due to slower than expected uptake of the HCV

Read more
28 Mar 2019 10:36

Genedrive Interim Loss Narrows As It Continues Focus On Hepatitis

LONDON (Alliance News) - Genedrive PLC on Thursday reported a reduction in its interim loss, as it continues to progress its hepatitis testing product.For the six months to the end of 2018,

Read more
28 Mar 2019 07:59

Genedrive losses narrow despite increased R&D costs

(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tick ahead slightly in the first half of its financial year but increased research and development costs kept the firm in the red.

Read more
15 Jan 2019 12:44

Genedrive Interim Revenue Rises On US And UK Government Contracts

LONDON (Alliance News) - Genedrive PLC said Tuesday it increased its first-half income and made "good progress" on two UK government funded projects.For the six months to the end

Read more
15 Jan 2019 10:17

Genedrive makes progress with HCV kit in first half

(Sharecast News) - Near-patient molecular diagnostics company Genedrive issued an unaudited update for the six months ended 31 December on Tuesday, reporting revenue of £1.5m, up from £1.3m year-on-year.

Read more
10 Dec 2018 16:23

BGF Investment Management Now Owns 12.8% Stake In Genedrive (ALLISS)

LONDON (Alliance News) - Genedrive PLC said Monday that BGF Investment Management Ltd now owns a 12.8% stake in the company.BGF's stake in the firm prior to Monday's deal, if any,

Read more
29 Nov 2018 13:56

Genedrive To Participate In Study For Use Of HCV Assay In Pharmacies

LONDON (Alliance News) - Genedrive PLC on Thursday said it will participate in an international multicentre trial to assess the impact of out-reach HCV diagnostics and therapy in a pharmacy versus

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.